Literature DB >> 9331705

Proteins M6 and F1 are required for efficient invasion of group A streptococci into cultured epithelial cells.

J Jadoun1, E Burstein, E Hanski, S Sela.   

Abstract

Group A streptococci were recently shown to be capable of invading human epithelial cell monolayers. Cell invasion might be an important virulence trait of streptococci that enable the pathogen to gain entry into deeper tissues after initial binding to host cells. Nothing is known concerning the nature of streptococcal components that mediate invasion. Using isogenic mutants of strain JRS4 that are defective in the expression of either M6 protein or protein F1, or both proteins, it was demonstrated that both adhesins are required for efficient invasion. Further more, expression of protein F1 on the surface of a non-invasive strain rendered the latter invasive, suggesting that protein F1 is directly involved in the invasion process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331705     DOI: 10.1007/978-1-4899-1825-3_121

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes.

Authors:  Patrik Nyberg; Takao Sakai; Kyu Hong Cho; Michael G Caparon; Reinhard Fässler; Lars Björck
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

2.  Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells.

Authors:  D Cue; P E Dombek; H Lam; P P Cleary
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 3.  Group A streptococcus and its antibiotic resistance.

Authors:  D Passàli; M Lauriello; G C Passàli; F M Passàli; L Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-02       Impact factor: 2.124

4.  Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development.

Authors:  Jeffrey B Locke; Ramy K Aziz; Mike R Vicknair; Victor Nizet; John T Buchanan
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.